nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—Azathioprine—systemic scleroderma	0.6	0.688	CbGbCtD
Ethacrynic acid—SLC22A6—Captopril—systemic scleroderma	0.0746	0.0856	CbGbCtD
Ethacrynic acid—ALB—Captopril—systemic scleroderma	0.0635	0.0729	CbGbCtD
Ethacrynic acid—ALB—Mycophenolate mofetil—systemic scleroderma	0.05	0.0574	CbGbCtD
Ethacrynic acid—ALB—Prednisone—systemic scleroderma	0.04	0.0459	CbGbCtD
Ethacrynic acid—SLC22A6—Methotrexate—systemic scleroderma	0.0236	0.027	CbGbCtD
Ethacrynic acid—ALB—Methotrexate—systemic scleroderma	0.0201	0.023	CbGbCtD
Ethacrynic acid—Hyperuricaemia—Mycophenolic acid—systemic scleroderma	0.00148	0.0115	CcSEcCtD
Ethacrynic acid—Gout—Mycophenolic acid—systemic scleroderma	0.00147	0.0115	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Mycophenolic acid—systemic scleroderma	0.0014	0.0109	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00138	0.0108	CcSEcCtD
Ethacrynic acid—Gout—Lisinopril—systemic scleroderma	0.00132	0.0103	CcSEcCtD
Ethacrynic acid—Jaundice—Pentoxifylline—systemic scleroderma	0.00126	0.00979	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Mycophenolate mofetil—systemic scleroderma	0.00117	0.0091	CcSEcCtD
Ethacrynic acid—Gout—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00904	CcSEcCtD
Ethacrynic acid—Deafness—Mycophenolic acid—systemic scleroderma	0.00111	0.00868	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Mycophenolate mofetil—systemic scleroderma	0.0011	0.0086	CcSEcCtD
Ethacrynic acid—Neutropenia—Captopril—systemic scleroderma	0.00102	0.00798	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00102	0.00796	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.000996	0.00776	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Leflunomide—systemic scleroderma	0.000964	0.00751	CcSEcCtD
Ethacrynic acid—Jaundice—Captopril—systemic scleroderma	0.000952	0.00742	CcSEcCtD
Ethacrynic acid—Vision blurred—Pentoxifylline—systemic scleroderma	0.000949	0.0074	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Pentoxifylline—systemic scleroderma	0.000934	0.00728	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.00092	0.00717	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Lisinopril—systemic scleroderma	0.000919	0.00717	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Azathioprine—systemic scleroderma	0.000916	0.00714	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Captopril—systemic scleroderma	0.000911	0.0071	CcSEcCtD
Ethacrynic acid—Malaise—Pentoxifylline—systemic scleroderma	0.000908	0.00708	CcSEcCtD
Ethacrynic acid—Deafness—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00685	CcSEcCtD
Ethacrynic acid—Convulsion—Pentoxifylline—systemic scleroderma	0.000872	0.0068	CcSEcCtD
Ethacrynic acid—Dysphagia—Mycophenolic acid—systemic scleroderma	0.000861	0.00671	CcSEcCtD
Ethacrynic acid—Anxiety—Pentoxifylline—systemic scleroderma	0.000854	0.00666	CcSEcCtD
Ethacrynic acid—Discomfort—Pentoxifylline—systemic scleroderma	0.000847	0.0066	CcSEcCtD
Ethacrynic acid—Neutropenia—Leflunomide—systemic scleroderma	0.000844	0.00658	CcSEcCtD
Ethacrynic acid—Confusional state—Pentoxifylline—systemic scleroderma	0.000828	0.00646	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Leflunomide—systemic scleroderma	0.000814	0.00635	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000805	0.00628	CcSEcCtD
Ethacrynic acid—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000805	0.00627	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000804	0.00627	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Azathioprine—systemic scleroderma	0.000795	0.0062	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00613	CcSEcCtD
Ethacrynic acid—Jaundice—Leflunomide—systemic scleroderma	0.000784	0.00611	CcSEcCtD
Ethacrynic acid—Anorexia—Pentoxifylline—systemic scleroderma	0.000783	0.0061	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Mycophenolic acid—systemic scleroderma	0.000777	0.00605	CcSEcCtD
Ethacrynic acid—Haematuria—Leflunomide—systemic scleroderma	0.000767	0.00598	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Leflunomide—systemic scleroderma	0.000751	0.00585	CcSEcCtD
Ethacrynic acid—Jaundice—Mycophenolic acid—systemic scleroderma	0.000748	0.00583	CcSEcCtD
Ethacrynic acid—Haematuria—Mycophenolic acid—systemic scleroderma	0.000732	0.0057	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00566	CcSEcCtD
Ethacrynic acid—Neutropenia—Lisinopril—systemic scleroderma	0.000725	0.00565	CcSEcCtD
Ethacrynic acid—Vision blurred—Captopril—systemic scleroderma	0.000719	0.0056	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000716	0.00558	CcSEcCtD
Ethacrynic acid—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000714	0.00557	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Captopril—systemic scleroderma	0.000708	0.00552	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000699	0.00545	CcSEcCtD
Ethacrynic acid—Malaise—Captopril—systemic scleroderma	0.000688	0.00536	CcSEcCtD
Ethacrynic acid—Chills—Azathioprine—systemic scleroderma	0.000686	0.00535	CcSEcCtD
Ethacrynic acid—Dysphagia—Mycophenolate mofetil—systemic scleroderma	0.000679	0.0053	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.000677	0.00528	CcSEcCtD
Ethacrynic acid—Anorexia—Mometasone—systemic scleroderma	0.000676	0.00527	CcSEcCtD
Ethacrynic acid—Jaundice—Lisinopril—systemic scleroderma	0.000674	0.00525	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Methotrexate—systemic scleroderma	0.000661	0.00515	CcSEcCtD
Ethacrynic acid—Haematuria—Lisinopril—systemic scleroderma	0.000659	0.00514	CcSEcCtD
Ethacrynic acid—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000649	0.00506	CcSEcCtD
Ethacrynic acid—Chills—Leflunomide—systemic scleroderma	0.000648	0.00505	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Lisinopril—systemic scleroderma	0.000645	0.00503	CcSEcCtD
Ethacrynic acid—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000642	0.00501	CcSEcCtD
Ethacrynic acid—Discomfort—Captopril—systemic scleroderma	0.000642	0.005	CcSEcCtD
Ethacrynic acid—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000635	0.00495	CcSEcCtD
Ethacrynic acid—Confusional state—Captopril—systemic scleroderma	0.000628	0.00489	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Methotrexate—systemic scleroderma	0.000625	0.00487	CcSEcCtD
Ethacrynic acid—Chills—Mycophenolic acid—systemic scleroderma	0.000618	0.00482	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000618	0.00482	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mometasone—systemic scleroderma	0.000616	0.0048	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000613	0.00478	CcSEcCtD
Ethacrynic acid—Fatigue—Mometasone—systemic scleroderma	0.000611	0.00476	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Captopril—systemic scleroderma	0.00061	0.00475	CcSEcCtD
Ethacrynic acid—Pain—Mometasone—systemic scleroderma	0.000606	0.00473	CcSEcCtD
Ethacrynic acid—Malaise—Azathioprine—systemic scleroderma	0.0006	0.00468	CcSEcCtD
Ethacrynic acid—Anorexia—Captopril—systemic scleroderma	0.000593	0.00463	CcSEcCtD
Ethacrynic acid—Vision blurred—Leflunomide—systemic scleroderma	0.000593	0.00462	CcSEcCtD
Ethacrynic acid—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00059	0.0046	CcSEcCtD
Ethacrynic acid—Asthenia—Pentoxifylline—systemic scleroderma	0.000589	0.00459	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000583	0.00455	CcSEcCtD
Ethacrynic acid—Tinnitus—Lisinopril—systemic scleroderma	0.000579	0.00451	CcSEcCtD
Ethacrynic acid—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000578	0.0045	CcSEcCtD
Ethacrynic acid—Malaise—Leflunomide—systemic scleroderma	0.000567	0.00442	CcSEcCtD
Ethacrynic acid—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000565	0.00441	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00441	CcSEcCtD
Ethacrynic acid—Vertigo—Leflunomide—systemic scleroderma	0.000565	0.0044	CcSEcCtD
Ethacrynic acid—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000562	0.00438	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mometasone—systemic scleroderma	0.00056	0.00437	CcSEcCtD
Ethacrynic acid—Discomfort—Azathioprine—systemic scleroderma	0.00056	0.00437	CcSEcCtD
Ethacrynic acid—Chills—Lisinopril—systemic scleroderma	0.000557	0.00434	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000557	0.00434	CcSEcCtD
Ethacrynic acid—Decreased appetite—Captopril—systemic scleroderma	0.000541	0.00422	CcSEcCtD
Ethacrynic acid—Malaise—Mycophenolic acid—systemic scleroderma	0.000541	0.00422	CcSEcCtD
Ethacrynic acid—Vertigo—Mycophenolic acid—systemic scleroderma	0.000539	0.0042	CcSEcCtD
Ethacrynic acid—Fatigue—Captopril—systemic scleroderma	0.000537	0.00418	CcSEcCtD
Ethacrynic acid—Anxiety—Leflunomide—systemic scleroderma	0.000533	0.00416	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000533	0.00415	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000532	0.00415	CcSEcCtD
Ethacrynic acid—Discomfort—Leflunomide—systemic scleroderma	0.000529	0.00412	CcSEcCtD
Ethacrynic acid—Vomiting—Pentoxifylline—systemic scleroderma	0.000522	0.00407	CcSEcCtD
Ethacrynic acid—Convulsion—Mycophenolic acid—systemic scleroderma	0.00052	0.00405	CcSEcCtD
Ethacrynic acid—Rash—Pentoxifylline—systemic scleroderma	0.000518	0.00404	CcSEcCtD
Ethacrynic acid—Dermatitis—Pentoxifylline—systemic scleroderma	0.000518	0.00403	CcSEcCtD
Ethacrynic acid—Headache—Pentoxifylline—systemic scleroderma	0.000515	0.00401	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Captopril—systemic scleroderma	0.000513	0.004	CcSEcCtD
Ethacrynic acid—Vision blurred—Lisinopril—systemic scleroderma	0.000509	0.00397	CcSEcCtD
Ethacrynic acid—Anxiety—Mycophenolic acid—systemic scleroderma	0.000509	0.00397	CcSEcCtD
Ethacrynic acid—Asthenia—Mometasone—systemic scleroderma	0.000509	0.00396	CcSEcCtD
Ethacrynic acid—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000507	0.00395	CcSEcCtD
Ethacrynic acid—Discomfort—Mycophenolic acid—systemic scleroderma	0.000505	0.00393	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000502	0.00392	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000501	0.00391	CcSEcCtD
Ethacrynic acid—Confusional state—Mycophenolic acid—systemic scleroderma	0.000494	0.00385	CcSEcCtD
Ethacrynic acid—Body temperature increased—Captopril—systemic scleroderma	0.000492	0.00384	CcSEcCtD
Ethacrynic acid—Anorexia—Leflunomide—systemic scleroderma	0.000489	0.00381	CcSEcCtD
Ethacrynic acid—Nausea—Pentoxifylline—systemic scleroderma	0.000488	0.0038	CcSEcCtD
Ethacrynic acid—Chills—Mycophenolate mofetil—systemic scleroderma	0.000488	0.0038	CcSEcCtD
Ethacrynic acid—Malaise—Lisinopril—systemic scleroderma	0.000487	0.0038	CcSEcCtD
Ethacrynic acid—Vertigo—Lisinopril—systemic scleroderma	0.000485	0.00378	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mometasone—systemic scleroderma	0.000485	0.00378	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000479	0.00374	CcSEcCtD
Ethacrynic acid—Anorexia—Mycophenolic acid—systemic scleroderma	0.000467	0.00364	CcSEcCtD
Ethacrynic acid—Anxiety—Lisinopril—systemic scleroderma	0.000458	0.00357	CcSEcCtD
Ethacrynic acid—Discomfort—Lisinopril—systemic scleroderma	0.000454	0.00354	CcSEcCtD
Ethacrynic acid—Vomiting—Mometasone—systemic scleroderma	0.000451	0.00351	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Azathioprine—systemic scleroderma	0.000448	0.00349	CcSEcCtD
Ethacrynic acid—Rash—Mometasone—systemic scleroderma	0.000447	0.00348	CcSEcCtD
Ethacrynic acid—Asthenia—Captopril—systemic scleroderma	0.000447	0.00348	CcSEcCtD
Ethacrynic acid—Dermatitis—Mometasone—systemic scleroderma	0.000447	0.00348	CcSEcCtD
Ethacrynic acid—Decreased appetite—Leflunomide—systemic scleroderma	0.000446	0.00348	CcSEcCtD
Ethacrynic acid—Confusional state—Lisinopril—systemic scleroderma	0.000445	0.00347	CcSEcCtD
Ethacrynic acid—Headache—Mometasone—systemic scleroderma	0.000444	0.00346	CcSEcCtD
Ethacrynic acid—Fatigue—Leflunomide—systemic scleroderma	0.000442	0.00345	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000439	0.00342	CcSEcCtD
Ethacrynic acid—Pain—Leflunomide—systemic scleroderma	0.000439	0.00342	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000432	0.00337	CcSEcCtD
Ethacrynic acid—Neutropenia—Prednisone—systemic scleroderma	0.000431	0.00336	CcSEcCtD
Ethacrynic acid—Body temperature increased—Azathioprine—systemic scleroderma	0.00043	0.00335	CcSEcCtD
Ethacrynic acid—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00333	CcSEcCtD
Ethacrynic acid—Diarrhoea—Captopril—systemic scleroderma	0.000426	0.00332	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000426	0.00332	CcSEcCtD
Ethacrynic acid—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00332	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Leflunomide—systemic scleroderma	0.000423	0.0033	CcSEcCtD
Ethacrynic acid—Fatigue—Mycophenolic acid—systemic scleroderma	0.000422	0.00329	CcSEcCtD
Ethacrynic acid—Nausea—Mometasone—systemic scleroderma	0.000421	0.00328	CcSEcCtD
Ethacrynic acid—Anorexia—Lisinopril—systemic scleroderma	0.00042	0.00328	CcSEcCtD
Ethacrynic acid—Pain—Mycophenolic acid—systemic scleroderma	0.000419	0.00326	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Prednisone—systemic scleroderma	0.000415	0.00324	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000411	0.0032	CcSEcCtD
Ethacrynic acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00041	0.0032	CcSEcCtD
Ethacrynic acid—Body temperature increased—Leflunomide—systemic scleroderma	0.000406	0.00316	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000403	0.00314	CcSEcCtD
Ethacrynic acid—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00313	CcSEcCtD
Ethacrynic acid—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000398	0.0031	CcSEcCtD
Ethacrynic acid—Vomiting—Captopril—systemic scleroderma	0.000396	0.00309	CcSEcCtD
Ethacrynic acid—Rash—Captopril—systemic scleroderma	0.000393	0.00306	CcSEcCtD
Ethacrynic acid—Dermatitis—Captopril—systemic scleroderma	0.000392	0.00306	CcSEcCtD
Ethacrynic acid—Headache—Captopril—systemic scleroderma	0.00039	0.00304	CcSEcCtD
Ethacrynic acid—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00304	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000387	0.00302	CcSEcCtD
Ethacrynic acid—Decreased appetite—Lisinopril—systemic scleroderma	0.000383	0.00299	CcSEcCtD
Ethacrynic acid—Fatigue—Lisinopril—systemic scleroderma	0.00038	0.00296	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000378	0.00295	CcSEcCtD
Ethacrynic acid—Pain—Lisinopril—systemic scleroderma	0.000377	0.00294	CcSEcCtD
Ethacrynic acid—Diarrhoea—Azathioprine—systemic scleroderma	0.000372	0.0029	CcSEcCtD
Ethacrynic acid—Nausea—Captopril—systemic scleroderma	0.00037	0.00288	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000369	0.00288	CcSEcCtD
Ethacrynic acid—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00287	CcSEcCtD
Ethacrynic acid—Asthenia—Leflunomide—systemic scleroderma	0.000368	0.00287	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Lisinopril—systemic scleroderma	0.000363	0.00283	CcSEcCtD
Ethacrynic acid—Neutropenia—Methotrexate—systemic scleroderma	0.00036	0.00281	CcSEcCtD
Ethacrynic acid—Asthenia—Mycophenolic acid—systemic scleroderma	0.000351	0.00274	CcSEcCtD
Ethacrynic acid—Diarrhoea—Leflunomide—systemic scleroderma	0.000351	0.00274	CcSEcCtD
Ethacrynic acid—Body temperature increased—Lisinopril—systemic scleroderma	0.000349	0.00272	CcSEcCtD
Ethacrynic acid—Vomiting—Azathioprine—systemic scleroderma	0.000345	0.00269	CcSEcCtD
Ethacrynic acid—Rash—Azathioprine—systemic scleroderma	0.000343	0.00267	CcSEcCtD
Ethacrynic acid—Dermatitis—Azathioprine—systemic scleroderma	0.000342	0.00267	CcSEcCtD
Ethacrynic acid—Headache—Azathioprine—systemic scleroderma	0.00034	0.00265	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00262	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000335	0.00261	CcSEcCtD
Ethacrynic acid—Pain—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00258	CcSEcCtD
Ethacrynic acid—Haematuria—Methotrexate—systemic scleroderma	0.000327	0.00255	CcSEcCtD
Ethacrynic acid—Vomiting—Leflunomide—systemic scleroderma	0.000326	0.00254	CcSEcCtD
Ethacrynic acid—Rash—Leflunomide—systemic scleroderma	0.000324	0.00252	CcSEcCtD
Ethacrynic acid—Dermatitis—Leflunomide—systemic scleroderma	0.000323	0.00252	CcSEcCtD
Ethacrynic acid—Nausea—Azathioprine—systemic scleroderma	0.000323	0.00252	CcSEcCtD
Ethacrynic acid—Headache—Leflunomide—systemic scleroderma	0.000321	0.00251	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Methotrexate—systemic scleroderma	0.00032	0.0025	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00248	CcSEcCtD
Ethacrynic acid—Asthenia—Lisinopril—systemic scleroderma	0.000316	0.00247	CcSEcCtD
Ethacrynic acid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000311	0.00243	CcSEcCtD
Ethacrynic acid—Rash—Mycophenolic acid—systemic scleroderma	0.000309	0.00241	CcSEcCtD
Ethacrynic acid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000308	0.0024	CcSEcCtD
Ethacrynic acid—Headache—Mycophenolic acid—systemic scleroderma	0.000307	0.00239	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00238	CcSEcCtD
Ethacrynic acid—Nausea—Leflunomide—systemic scleroderma	0.000305	0.00238	CcSEcCtD
Ethacrynic acid—Vision blurred—Prednisone—systemic scleroderma	0.000302	0.00236	CcSEcCtD
Ethacrynic acid—Diarrhoea—Lisinopril—systemic scleroderma	0.000302	0.00235	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisone—systemic scleroderma	0.000298	0.00232	CcSEcCtD
Ethacrynic acid—Nausea—Mycophenolic acid—systemic scleroderma	0.000291	0.00227	CcSEcCtD
Ethacrynic acid—Malaise—Prednisone—systemic scleroderma	0.000289	0.00226	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisone—systemic scleroderma	0.000288	0.00225	CcSEcCtD
Ethacrynic acid—Tinnitus—Methotrexate—systemic scleroderma	0.000287	0.00224	CcSEcCtD
Ethacrynic acid—Vomiting—Lisinopril—systemic scleroderma	0.00028	0.00219	CcSEcCtD
Ethacrynic acid—Rash—Lisinopril—systemic scleroderma	0.000278	0.00217	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisone—systemic scleroderma	0.000278	0.00217	CcSEcCtD
Ethacrynic acid—Dermatitis—Lisinopril—systemic scleroderma	0.000278	0.00217	CcSEcCtD
Ethacrynic acid—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00216	CcSEcCtD
Ethacrynic acid—Chills—Methotrexate—systemic scleroderma	0.000276	0.00215	CcSEcCtD
Ethacrynic acid—Headache—Lisinopril—systemic scleroderma	0.000276	0.00215	CcSEcCtD
Ethacrynic acid—Anxiety—Prednisone—systemic scleroderma	0.000272	0.00212	CcSEcCtD
Ethacrynic acid—Discomfort—Prednisone—systemic scleroderma	0.00027	0.0021	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000264	0.00206	CcSEcCtD
Ethacrynic acid—Nausea—Lisinopril—systemic scleroderma	0.000262	0.00204	CcSEcCtD
Ethacrynic acid—Vision blurred—Methotrexate—systemic scleroderma	0.000253	0.00197	CcSEcCtD
Ethacrynic acid—Anorexia—Prednisone—systemic scleroderma	0.00025	0.00195	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000249	0.00194	CcSEcCtD
Ethacrynic acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00191	CcSEcCtD
Ethacrynic acid—Rash—Mycophenolate mofetil—systemic scleroderma	0.000244	0.0019	CcSEcCtD
Ethacrynic acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000243	0.0019	CcSEcCtD
Ethacrynic acid—Headache—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00189	CcSEcCtD
Ethacrynic acid—Malaise—Methotrexate—systemic scleroderma	0.000242	0.00189	CcSEcCtD
Ethacrynic acid—Vertigo—Methotrexate—systemic scleroderma	0.000241	0.00188	CcSEcCtD
Ethacrynic acid—Convulsion—Methotrexate—systemic scleroderma	0.000232	0.00181	CcSEcCtD
Ethacrynic acid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00179	CcSEcCtD
Ethacrynic acid—Decreased appetite—Prednisone—systemic scleroderma	0.000228	0.00177	CcSEcCtD
Ethacrynic acid—Fatigue—Prednisone—systemic scleroderma	0.000226	0.00176	CcSEcCtD
Ethacrynic acid—Discomfort—Methotrexate—systemic scleroderma	0.000226	0.00176	CcSEcCtD
Ethacrynic acid—Confusional state—Methotrexate—systemic scleroderma	0.000221	0.00172	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisone—systemic scleroderma	0.000216	0.00168	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000214	0.00167	CcSEcCtD
Ethacrynic acid—Anorexia—Methotrexate—systemic scleroderma	0.000209	0.00163	CcSEcCtD
Ethacrynic acid—Body temperature increased—Prednisone—systemic scleroderma	0.000207	0.00161	CcSEcCtD
Ethacrynic acid—Decreased appetite—Methotrexate—systemic scleroderma	0.00019	0.00148	CcSEcCtD
Ethacrynic acid—Fatigue—Methotrexate—systemic scleroderma	0.000189	0.00147	CcSEcCtD
Ethacrynic acid—Asthenia—Prednisone—systemic scleroderma	0.000188	0.00146	CcSEcCtD
Ethacrynic acid—Pain—Methotrexate—systemic scleroderma	0.000187	0.00146	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Methotrexate—systemic scleroderma	0.00018	0.00141	CcSEcCtD
Ethacrynic acid—Diarrhoea—Prednisone—systemic scleroderma	0.000179	0.0014	CcSEcCtD
Ethacrynic acid—Body temperature increased—Methotrexate—systemic scleroderma	0.000173	0.00135	CcSEcCtD
Ethacrynic acid—Vomiting—Prednisone—systemic scleroderma	0.000167	0.0013	CcSEcCtD
Ethacrynic acid—Rash—Prednisone—systemic scleroderma	0.000165	0.00129	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisone—systemic scleroderma	0.000165	0.00129	CcSEcCtD
Ethacrynic acid—Headache—Prednisone—systemic scleroderma	0.000164	0.00128	CcSEcCtD
Ethacrynic acid—Asthenia—Methotrexate—systemic scleroderma	0.000157	0.00122	CcSEcCtD
Ethacrynic acid—Nausea—Prednisone—systemic scleroderma	0.000156	0.00121	CcSEcCtD
Ethacrynic acid—Diarrhoea—Methotrexate—systemic scleroderma	0.00015	0.00117	CcSEcCtD
Ethacrynic acid—Vomiting—Methotrexate—systemic scleroderma	0.000139	0.00108	CcSEcCtD
Ethacrynic acid—Rash—Methotrexate—systemic scleroderma	0.000138	0.00108	CcSEcCtD
Ethacrynic acid—Dermatitis—Methotrexate—systemic scleroderma	0.000138	0.00107	CcSEcCtD
Ethacrynic acid—Headache—Methotrexate—systemic scleroderma	0.000137	0.00107	CcSEcCtD
Ethacrynic acid—Nausea—Methotrexate—systemic scleroderma	0.00013	0.00101	CcSEcCtD
